Taking Stock of the Biodefense Boom
2 September 2011
By Jocelyn Kaiser, Science
Ten years after the anthrax
letters-and after billions of dollars of investment in labs and
research-debate continues over how much safer the country
is.
The anthrax mailings that petrified
Americans soon after the 9/11 attacks a decade ago this fall,
killing five people and sickening 17, led to an explosion of
biodefense research in the United States. Nearly $19 billion has
been spent-a huge increase over previous levels and about one-third
of the entire $60 billion the country has put into biodefense
preparedness. Although the influx of funds has yielded scientific
insights and some new products, how much safer the country is as a
result is a matter of debate.
Full article
DISCLAIMER
The links and content above are provided for your convenience to provide further information and do not constitute an endorsement by Bavarian Nordic. We have no control over the nature, content and availability of the sites that are being linked to and thus we assume no responsibility for the privacy practices on such websites.
